Privacy, Pediatrics, and Policy

Pharmaceutical Executive

Pharmaceutical Executive, Pharmaceutical Executive-03-01-2001, Volume 0, Issue 0

FDA proposals for expanding the pediatric study program include tax incentives and }transferable exclusivity.}